Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations
2006
Estimating the reproducibility of psychological science
2015 StandoutScience
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Creating Clinical Practice Guidelines We Can Trust, Use, and Share
2013
Effects of Calcium Supplementation During Pregnancy on Maternal, Fetal and Birth Outcomes
2012
Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomes
2002
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Early childhood development coming of age: science through the life course
2016 Standout
How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data
2009 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Can interventions improve health services from informal private providers in low and middle-income countries? A comprehensive review of the literature
2010
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Scale up of services for mental health in low-income and middle-income countries
2011
A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
2007
A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells
2009
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Consort 2010 statement: extension to cluster randomised trials
2012 Standout
Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery
2011 Standout
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
2013 Standout
Measuring inconsistency in meta-analyses
2003 Standout
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
Equipoise and the Dilemma of Randomized Clinical Trials
2011
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
2011 Standout
Symbols were superior to numbers for presenting strength of recommendations to health care consumers: a randomized trial
2007
Reporting bias in medical research - a narrative review
2010
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
2006
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
CLINICAL JUDGMENT AND CLINICAL PRACTICE GUIDELINES
2000
GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
2013
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
2008
Mental health of young people: a global public-health challenge
2007 Standout
Rheumatoid arthritis
2010 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
The annual cost of blood transfusions in the UK
2003
Effect of Multiple Micronutrient Supplementation on Pregnancy and Infant Outcomes: A Systematic Review
2012
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006
Cell salvage for minimising perioperative allogeneic blood transfusion
2010
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
How pharmaceutical industry funding affects trial outcomes: Causal structures and responses
2008
Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes
2010
Influence of drug company authorship and sponsorship on drug trial outcomes
2007
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Chronic Kidney Disease
2016 Standout
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
2003 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
2013
An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations
2006
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Control of household air pollution for child survival: estimates for intervention impacts
2013
Systems to rate the strength of scientific evidence.
2002
Psychological therapies for people with borderline personality disorder
2012
Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review
2017
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Measuring the Prevalence of Questionable Research Practices With Incentives for Truth Telling
2012 Standout
The preregistration revolution
2018 Standout
Misconduct accounts for the majority of retracted scientific publications
2012 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
2006
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
2008
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
2015
Industry sponsorship and research outcome
2017 Standout
Works of Suzanne Hill being referenced
Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system
2005
Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results
2013
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
2012
Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis
2006
The effects of information framing on the practices of physicians
1999
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group
2004
Transparent Development of the WHO Rapid Advice Guidelines
2007
Cost–effectiveness thresholds: pros and cons
2016
The GRADE approach and Bradford Hill's criteria for causation
2010
Problems With the Interpretation of Pharmacoeconomic Analyses
2000
Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement
2011
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2000
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
2016
Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders
2010
Medical specialists and pharmaceutical industry‐sponsored research: a survey of the Australian experience
2005
The role of C ochrane reviews in informing international guidelines: a case study of using the G rading of R ecommendations, A ssessment, D evelopment and E valuation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2014